RNA Oncoimmune Phenotyping of HPV-Positive p16-Positive Oropharyngeal Squamous Cell Carcinomas by Nodal Status
暂无分享,去创建一个
Wesley H. Stepp | D. Hayes | A. Mazul | J. Zevallos | T. Hackman | M. Mamdani | D. Farquhar | S. Sheth | Mohammed Mamdani
[1] Brian O'Sullivan,et al. Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study , 2018, The British journal of radiology.
[2] Christopher C. Griffith,et al. A Correlative Analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 Expression in Oropharyngeal Squamous Cell Carcinoma , 2018, Molecular Cancer Therapeutics.
[3] A. Cesano,et al. Bringing the Next Generation of Immuno-Oncology Biomarkers to the Clinic , 2018, Biomedicines.
[4] Carol Colasacco,et al. Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists. , 2017, Archives of pathology & laboratory medicine.
[5] J. Lunceford,et al. IFN-&ggr;–related mRNA profile predicts clinical response to PD-1 blockade , 2017, The Journal of clinical investigation.
[6] H. Quon,et al. Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment. , 2017, Oral oncology.
[7] Brian O'Sullivan,et al. Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.
[8] C. Chung,et al. E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Patrick Danaher,et al. Gene expression markers of Tumor Infiltrating Leukocytes , 2016, Journal of Immunotherapy for Cancer.
[10] C. von Buchwald,et al. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status , 2017, European Archives of Oto-Rhino-Laryngology.
[11] M. Goodman,et al. Incidence of Oropharyngeal Cancer Among Elderly Patients in the United States. , 2016, JAMA oncology.
[12] Erliang Zeng,et al. Metastatic model of HPV+ oropharyngeal squamous cell carcinoma demonstrates heterogeneity in tumor metastasis , 2016, Oncotarget.
[13] J. Kramer,et al. Prognostic Significance of p16 Cellular Localization in Oropharyngeal Squamous Cell Carcinoma. , 2016, Annals of clinical and laboratory science.
[14] J. Tepper,et al. Phase 2 Trial of De-intensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma. , 2015, International journal of radiation oncology, biology, physics.
[15] E. Mardis,et al. Development and verification of the PAM50-based Prosigna breast cancer gene signature assay , 2015, BMC Medical Genomics.
[16] R. Ferris,et al. Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life outcomes. , 2015, JAMA otolaryngology-- head & neck surgery.
[17] Steven J. M. Jones,et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.
[18] Kevin P. White,et al. Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes , 2014, Clinical Cancer Research.
[19] A. Psyrri,et al. The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[20] D. Hartl,et al. Human papilloma virus testing in oropharyngeal squamous cell carcinoma: what the clinician should know. , 2014, Oral oncology.
[21] Wei Xu,et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] G. Weinstein,et al. Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control. , 2012, Archives of otolaryngology--head & neck surgery.
[23] A. Olshan,et al. Different cellular p16INK4a localisation may signal different survival outcomes in head and neck cancer , 2012, British Journal of Cancer.
[24] J. Hocking,et al. Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers , 2011, British Journal of Cancer.
[25] K. Ang,et al. Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.
[26] C. Moskaluk,et al. Intensity‐modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status , 2010, Cancer.
[27] A. Nobel,et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] Jennifer L. Osborn,et al. Direct multiplexed measurement of gene expression with color-coded probe pairs , 2008, Nature Biotechnology.
[29] H. Dienes,et al. Combined analysis of HPV‐DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer , 2007, International journal of cancer.
[30] D. Rimm,et al. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] D. Sessions,et al. The Influence of Lymph Node Metastasis in the Treatment of Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Larynx, and Hypopharynx: N0 Versus N+ , 2005, The Laryngoscope.
[32] M. Gillison,et al. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. , 2004, Seminars in oncology.
[33] D. Lowy,et al. A causal role for human papillomavirus in head and neck cancer , 2004, The Lancet.
[34] R. Weber,et al. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.